Search

Senators Jerry Moran (R-Kan.) and Mark Warner (D-Va.), co-signed by Senators Roy Blunt (R-Mo.) and Amy Klobuchar (D-Minn.), re-introduced the Startup Act today. The bill would enact an array of innovation policies, including reauthorizing Regional Innovation Strategies, creating a new commercialization grant program, and implementing a startup visa.

Support for the recently introduced Startup Act continues to build across the country. The legislation, profiled earlier in the Digest, would accelerate the commercialization of university research, improve the regulatory processes at the federal, state and local levels, and modernize a critical Economic Development Administration (EDA) program to promote innovation and spur economic growth.

The 116^th Congress has already advanced policies to affect regional innovation economies, and much more is poised to happen once both chambers return in September. In addition to completing the FY 2019 budget (see our Feb. coverage), this session has seen Regional Innovation Strategies legislation pass the House and Senate (albeit in different bills); the Senate working toward an overhaul of the Small Business Administration; and, the start of the FY 2020 budget process.

Tuesday’s elections resulted in a Democratic majority in the House, but the changes for the next Congress go far beyond this outcome. Flipping party control means new chairs for every committee in the House; many Senate Republicans in leadership positions are reaching their party’s term limits, yielding new committee seniority; and, retirements and incumbent losses yield further changes. For the bipartisan issues of science and innovation, this shake up will produce new opportunities and uncertainties.

In an unexpected twist, the FY 2017 budget passed earlier this month by Congress has more dislikes than likes for evidence-based program and policy design, despite being embraced strongly by both Presidents Donald Trump and Barack Obama. Masked under a variety of different nomenclatures – performance contracting, social impact bonds, pay for success, for example – evidence-based programming incorporates rigorous metrics to assess the effectiveness of public policy toward meeting its goals and basing expenditures accordingly.

The U.S. House Science Committee released a letter last week reasserting the majority party’s interest in setting R&D priorities for federal science agencies and supporting appropriation levels that generally align with the White House’s budget blueprint. The letter notes priorities for most of the $42 billion in R&D budgets within the committee’s purview.

This week we take a look at the Trump administration's proposed $54 billion increase in defense spending, NDD United's letter to Congress (which SSTI signed), and testimony in favor of TBED funding.